CNY 7.26
(0.55%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 335.61 Million CNY | -3.0% |
2022 | 346.01 Million CNY | -1.81% |
2021 | 352.39 Million CNY | 16.3% |
2020 | 302.99 Million CNY | -11.12% |
2019 | 340.91 Million CNY | 27.09% |
2018 | 268.25 Million CNY | 16.64% |
2017 | 229.98 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 86.61 Million CNY | 14.67% |
2024 Q2 | 82.91 Million CNY | -4.27% |
2024 Q3 | 88.36 Million CNY | 6.58% |
2023 Q1 | 76.32 Million CNY | -2.54% |
2023 FY | 335.61 Million CNY | -3.0% |
2023 Q4 | 75.52 Million CNY | -20.99% |
2023 Q3 | 95.58 Million CNY | 8.4% |
2023 Q2 | 88.17 Million CNY | 15.53% |
2022 Q3 | 102.39 Million CNY | 36.71% |
2022 Q2 | 74.89 Million CNY | -17.15% |
2022 Q1 | 90.4 Million CNY | 6.83% |
2022 FY | 346.01 Million CNY | -1.81% |
2022 Q4 | 78.31 Million CNY | -23.51% |
2021 Q2 | 89.24 Million CNY | -1.72% |
2021 Q1 | 90.8 Million CNY | 1136.9% |
2021 FY | 352.39 Million CNY | 16.3% |
2021 Q4 | 84.62 Million CNY | -3.53% |
2021 Q3 | 87.71 Million CNY | -1.71% |
2020 Q1 | 39.14 Million CNY | 390.78% |
2020 FY | 302.99 Million CNY | -11.12% |
2020 Q4 | 7.34 Million CNY | -93.29% |
2020 Q3 | 109.35 Million CNY | 68.06% |
2020 Q2 | 65.07 Million CNY | 66.22% |
2019 Q3 | 128.49 Million CNY | 0.0% |
2019 Q4 | 7.97 Million CNY | -93.79% |
2019 FY | 340.91 Million CNY | 27.09% |
2018 FY | 268.25 Million CNY | 16.64% |
2017 FY | 229.98 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Shanghai Runda Medical Technology Co., Ltd. | 2.41 Billion CNY | 86.124% |
Joinn Laboratories(China)Co.,Ltd. | 1.01 Billion CNY | 66.862% |
WuXi AppTec Co., Ltd. | 16.27 Billion CNY | 97.938% |
Autobio Diagnostics Co., Ltd. | 2.83 Billion CNY | 88.149% |
Thalys Medical Technology Group Inc. | 389.73 Million CNY | 13.886% |
Guangzhou Kingmed Diagnostics Group Co., Ltd. | 3.11 Billion CNY | 89.226% |